Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Also Known As:

Antiplatelet Drugs; Blood Platelet Aggregation Inhibitors; Blood Platelet Antagonists; Blood Platelet Antiaggregants; Platelet Inhibitors; Agent, Antiplatelet; Aggregation Inhibitor, Platelet; Antagonist, Blood Platelet; Antagonist, Platelet; Antiaggregant, Blood Platelet; Antiaggregant, Platelet; Drug, Antiplatelet; Inhibitor, Platelet; Inhibitor, Platelet Aggregation; PAR 1 Antagonists; Platelet Antagonist, Blood; Platelet Antiaggregant, Blood; Protease Activated Receptor 1 Antagonists; Antiaggregants, Platelet; Antiplatelet Agent; Antiplatelet Agents; Antiplatelet Drug; Blood Platelet Aggregation Inhibitor; Blood Platelet Antagonist; Blood Platelet Antiaggregant; PAR-1 Antagonists; Platelet Aggregation Inhibitor; Platelet Antagonist; Platelet Antagonists; Platelet Antiaggregant; Platelet Antiaggregants; Platelet Inhibitor; Protease-Activated Receptor-1 Antagonists

Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Therapeutic Uses: 47080
    - Hematologic Agents: 2
      - Platelet Aggregation Inhibitors: 5480

Ryan G Schmer Selected Research

Ryan G Schmer Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure